ニンテダニブAPIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Nintedanib API Market Insights, Forecast to 2028

• レポートコード：QY2207E01760 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のニンテダニブAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニンテダニブAPIの世界市場のxxx％を占める「純度≥98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のニンテダニブAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのニンテダニブAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのニンテダニブAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ニンテダニブAPIのグローバル主要メーカーには、Teva、Sunshine Pharmaceutical、Fermion、Tecoland、Enantiotech、Guoding Pharmaceutical、Haiwo、Beijing Cooperate Pharmaceutical、Hangzhou Longshine Bio-Techなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ニンテダニブAPI市場は、種類と用途によって区分されます。世界のニンテダニブAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度≥98％、純度≥99％ 【用途別セグメント】 製薬、医学研究、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ニンテダニブAPI製品概要 - 種類別市場（純度≥98％、純度≥99％） - 用途別市場（製薬、医学研究、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のニンテダニブAPI販売量予測2017-2028 - 世界のニンテダニブAPI売上予測2017-2028 - ニンテダニブAPIの地域別販売量 - ニンテダニブAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ニンテダニブAPI販売量 - 主要メーカー別ニンテダニブAPI売上 - 主要メーカー別ニンテダニブAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度≥98％、純度≥99％） - ニンテダニブAPIの種類別販売量 - ニンテダニブAPIの種類別売上 - ニンテダニブAPIの種類別価格 ・用途別市場規模（製薬、医学研究、その他） - ニンテダニブAPIの用途別販売量 - ニンテダニブAPIの用途別売上 - ニンテダニブAPIの用途別価格 ・北米市場 - 北米のニンテダニブAPI市場規模（種類別、用途別） - 主要国別のニンテダニブAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのニンテダニブAPI市場規模（種類別、用途別） - 主要国別のニンテダニブAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のニンテダニブAPI市場規模（種類別、用途別） - 主要国別のニンテダニブAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のニンテダニブAPI市場規模（種類別、用途別） - 主要国別のニンテダニブAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのニンテダニブAPI市場規模（種類別、用途別） - 主要国別のニンテダニブAPI市場規模（トルコ、サウジアラビア） ・企業情報 Teva、Sunshine Pharmaceutical、Fermion、Tecoland、Enantiotech、Guoding Pharmaceutical、Haiwo、Beijing Cooperate Pharmaceutical、Hangzhou Longshine Bio-Tech ・産業チェーン及び販売チャネル分析 - ニンテダニブAPIの産業チェーン分析 - ニンテダニブAPIの原材料 - ニンテダニブAPIの生産プロセス - ニンテダニブAPIの販売及びマーケティング - ニンテダニブAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ニンテダニブAPIの産業動向 - ニンテダニブAPIのマーケットドライバー - ニンテダニブAPIの課題 - ニンテダニブAPIの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Nintedanib API Market
Due to the COVID-19 pandemic, the global Nintedanib API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥98% accounting for % of the Nintedanib API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Nintedanib API market size is valued at US$ million in 2021, while the US and Europe Nintedanib API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nintedanib API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Nintedanib API include Teva, Sunshine Pharmaceutical, Fermion, Tecoland, Enantiotech, Guoding Pharmaceutical, Haiwo, Beijing Cooperate Pharmaceutical and Hangzhou Longshine Bio-Tech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Nintedanib API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Nintedanib API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Nintedanib API Scope and Segment
Nintedanib API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nintedanib API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Pharmaceutical
Medical Research
Other
By Company
Teva
Sunshine Pharmaceutical
Fermion
Tecoland
Enantiotech
Guoding Pharmaceutical
Haiwo
Beijing Cooperate Pharmaceutical
Hangzhou Longshine Bio-Tech
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Nintedanib API Product Introduction
1.2 Market by Type
1.2.1 Global Nintedanib API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Market by Application
1.3.1 Global Nintedanib API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Medical Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Nintedanib API Production
2.1 Global Nintedanib API Production Capacity (2017-2028)
2.2 Global Nintedanib API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Nintedanib API Production by Region
2.3.1 Global Nintedanib API Historic Production by Region (2017-2022)
2.3.2 Global Nintedanib API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
3 Global Nintedanib API Sales in Volume & Value Estimates and Forecasts
3.1 Global Nintedanib API Sales Estimates and Forecasts 2017-2028
3.2 Global Nintedanib API Revenue Estimates and Forecasts 2017-2028
3.3 Global Nintedanib API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Nintedanib API Sales by Region
3.4.1 Global Nintedanib API Sales by Region (2017-2022)
3.4.2 Global Sales Nintedanib API by Region (2023-2028)
3.5 Global Nintedanib API Revenue by Region
3.5.1 Global Nintedanib API Revenue by Region (2017-2022)
3.5.2 Global Nintedanib API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Nintedanib API Production Capacity by Manufacturers
4.2 Global Nintedanib API Sales by Manufacturers
4.2.1 Global Nintedanib API Sales by Manufacturers (2017-2022)
4.2.2 Global Nintedanib API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Nintedanib API in 2021
4.3 Global Nintedanib API Revenue by Manufacturers
4.3.1 Global Nintedanib API Revenue by Manufacturers (2017-2022)
4.3.2 Global Nintedanib API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Nintedanib API Revenue in 2021
4.4 Global Nintedanib API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Nintedanib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Nintedanib API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Nintedanib API Sales by Type
5.1.1 Global Nintedanib API Historical Sales by Type (2017-2022)
5.1.2 Global Nintedanib API Forecasted Sales by Type (2023-2028)
5.1.3 Global Nintedanib API Sales Market Share by Type (2017-2028)
5.2 Global Nintedanib API Revenue by Type
5.2.1 Global Nintedanib API Historical Revenue by Type (2017-2022)
5.2.2 Global Nintedanib API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Nintedanib API Revenue Market Share by Type (2017-2028)
5.3 Global Nintedanib API Price by Type
5.3.1 Global Nintedanib API Price by Type (2017-2022)
5.3.2 Global Nintedanib API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Nintedanib API Sales by Application
6.1.1 Global Nintedanib API Historical Sales by Application (2017-2022)
6.1.2 Global Nintedanib API Forecasted Sales by Application (2023-2028)
6.1.3 Global Nintedanib API Sales Market Share by Application (2017-2028)
6.2 Global Nintedanib API Revenue by Application
6.2.1 Global Nintedanib API Historical Revenue by Application (2017-2022)
6.2.2 Global Nintedanib API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Nintedanib API Revenue Market Share by Application (2017-2028)
6.3 Global Nintedanib API Price by Application
6.3.1 Global Nintedanib API Price by Application (2017-2022)
6.3.2 Global Nintedanib API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Nintedanib API Market Size by Type
7.1.1 North America Nintedanib API Sales by Type (2017-2028)
7.1.2 North America Nintedanib API Revenue by Type (2017-2028)
7.2 North America Nintedanib API Market Size by Application
7.2.1 North America Nintedanib API Sales by Application (2017-2028)
7.2.2 North America Nintedanib API Revenue by Application (2017-2028)
7.3 North America Nintedanib API Sales by Country
7.3.1 North America Nintedanib API Sales by Country (2017-2028)
7.3.2 North America Nintedanib API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Nintedanib API Market Size by Type
8.1.1 Europe Nintedanib API Sales by Type (2017-2028)
8.1.2 Europe Nintedanib API Revenue by Type (2017-2028)
8.2 Europe Nintedanib API Market Size by Application
8.2.1 Europe Nintedanib API Sales by Application (2017-2028)
8.2.2 Europe Nintedanib API Revenue by Application (2017-2028)
8.3 Europe Nintedanib API Sales by Country
8.3.1 Europe Nintedanib API Sales by Country (2017-2028)
8.3.2 Europe Nintedanib API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Nintedanib API Market Size by Type
9.1.1 Asia Pacific Nintedanib API Sales by Type (2017-2028)
9.1.2 Asia Pacific Nintedanib API Revenue by Type (2017-2028)
9.2 Asia Pacific Nintedanib API Market Size by Application
9.2.1 Asia Pacific Nintedanib API Sales by Application (2017-2028)
9.2.2 Asia Pacific Nintedanib API Revenue by Application (2017-2028)
9.3 Asia Pacific Nintedanib API Sales by Region
9.3.1 Asia Pacific Nintedanib API Sales by Region (2017-2028)
9.3.2 Asia Pacific Nintedanib API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Nintedanib API Market Size by Type
10.1.1 Latin America Nintedanib API Sales by Type (2017-2028)
10.1.2 Latin America Nintedanib API Revenue by Type (2017-2028)
10.2 Latin America Nintedanib API Market Size by Application
10.2.1 Latin America Nintedanib API Sales by Application (2017-2028)
10.2.2 Latin America Nintedanib API Revenue by Application (2017-2028)
10.3 Latin America Nintedanib API Sales by Country
10.3.1 Latin America Nintedanib API Sales by Country (2017-2028)
10.3.2 Latin America Nintedanib API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Nintedanib API Market Size by Type
11.1.1 Middle East and Africa Nintedanib API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Nintedanib API Revenue by Type (2017-2028)
11.2 Middle East and Africa Nintedanib API Market Size by Application
11.2.1 Middle East and Africa Nintedanib API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Nintedanib API Revenue by Application (2017-2028)
11.3 Middle East and Africa Nintedanib API Sales by Country
11.3.1 Middle East and Africa Nintedanib API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Nintedanib API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Overview
12.1.3 Teva Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Teva Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva Recent Developments
12.2 Sunshine Pharmaceutical
12.2.1 Sunshine Pharmaceutical Corporation Information
12.2.2 Sunshine Pharmaceutical Overview
12.2.3 Sunshine Pharmaceutical Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Sunshine Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Sunshine Pharmaceutical Recent Developments
12.3 Fermion
12.3.1 Fermion Corporation Information
12.3.2 Fermion Overview
12.3.3 Fermion Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Fermion Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Fermion Recent Developments
12.4 Tecoland
12.4.1 Tecoland Corporation Information
12.4.2 Tecoland Overview
12.4.3 Tecoland Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Tecoland Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Tecoland Recent Developments
12.5 Enantiotech
12.5.1 Enantiotech Corporation Information
12.5.2 Enantiotech Overview
12.5.3 Enantiotech Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Enantiotech Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Enantiotech Recent Developments
12.6 Guoding Pharmaceutical
12.6.1 Guoding Pharmaceutical Corporation Information
12.6.2 Guoding Pharmaceutical Overview
12.6.3 Guoding Pharmaceutical Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Guoding Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Guoding Pharmaceutical Recent Developments
12.7 Haiwo
12.7.1 Haiwo Corporation Information
12.7.2 Haiwo Overview
12.7.3 Haiwo Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Haiwo Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Haiwo Recent Developments
12.8 Beijing Cooperate Pharmaceutical
12.8.1 Beijing Cooperate Pharmaceutical Corporation Information
12.8.2 Beijing Cooperate Pharmaceutical Overview
12.8.3 Beijing Cooperate Pharmaceutical Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Beijing Cooperate Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Beijing Cooperate Pharmaceutical Recent Developments
12.9 Hangzhou Longshine Bio-Tech
12.9.1 Hangzhou Longshine Bio-Tech Corporation Information
12.9.2 Hangzhou Longshine Bio-Tech Overview
12.9.3 Hangzhou Longshine Bio-Tech Nintedanib API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Hangzhou Longshine Bio-Tech Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hangzhou Longshine Bio-Tech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Nintedanib API Industry Chain Analysis
13.2 Nintedanib API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Nintedanib API Production Mode & Process
13.4 Nintedanib API Sales and Marketing
13.4.1 Nintedanib API Sales Channels
13.4.2 Nintedanib API Distributors
13.5 Nintedanib API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Nintedanib API Industry Trends
14.2 Nintedanib API Market Drivers
14.3 Nintedanib API Market Challenges
14.4 Nintedanib API Market Restraints
15 Key Finding in The Global Nintedanib API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Nintedanib API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥98%
Table 3. Major Manufacturers of Purity ≥99%
Table 4. Global Nintedanib API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Nintedanib API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Nintedanib API Production by Region (2017-2022) & (Tons)
Table 7. Global Nintedanib API Production Market Share by Region (2017-2022)
Table 8. Global Nintedanib API Production by Region (2023-2028) & (Tons)
Table 9. Global Nintedanib API Production Market Share by Region (2023-2028)
Table 10. Global Nintedanib API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Nintedanib API Sales by Region (2017-2022) & (Tons)
Table 12. Global Nintedanib API Sales Market Share by Region (2017-2022)
Table 13. Global Nintedanib API Sales by Region (2023-2028) & (Tons)
Table 14. Global Nintedanib API Sales Market Share by Region (2023-2028)
Table 15. Global Nintedanib API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Nintedanib API Revenue Market Share by Region (2017-2022)
Table 17. Global Nintedanib API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Nintedanib API Revenue Market Share by Region (2023-2028)
Table 19. Global Nintedanib API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Nintedanib API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Nintedanib API Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Nintedanib API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Nintedanib API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Nintedanib API Revenue Share by Manufacturers (2017-2022)
Table 25. Nintedanib API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Nintedanib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Nintedanib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nintedanib API as of 2021)
Table 28. Nintedanib API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Nintedanib API Product Offered
Table 30. Date of Manufacturers Enter into Nintedanib API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 33. Global Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 34. Global Nintedanib API Sales Share by Type (2017-2022)
Table 35. Global Nintedanib API Sales Share by Type (2023-2028)
Table 36. Global Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Nintedanib API Revenue Share by Type (2017-2022)
Table 39. Global Nintedanib API Revenue Share by Type (2023-2028)
Table 40. Nintedanib API Price by Type (2017-2022) & (US$/Kg)
Table 41. Global Nintedanib API Price Forecast by Type (2023-2028) & (US$/Kg)
Table 42. Global Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 43. Global Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 44. Global Nintedanib API Sales Share by Application (2017-2022)
Table 45. Global Nintedanib API Sales Share by Application (2023-2028)
Table 46. Global Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Nintedanib API Revenue Share by Application (2017-2022)
Table 49. Global Nintedanib API Revenue Share by Application (2023-2028)
Table 50. Nintedanib API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Nintedanib API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 53. North America Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 54. North America Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 57. North America Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 58. North America Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Nintedanib API Sales by Country (2017-2022) & (Tons)
Table 61. North America Nintedanib API Sales by Country (2023-2028) & (Tons)
Table 62. North America Nintedanib API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Nintedanib API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 65. Europe Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 66. Europe Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 69. Europe Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 70. Europe Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Nintedanib API Sales by Country (2017-2022) & (Tons)
Table 73. Europe Nintedanib API Sales by Country (2023-2028) & (Tons)
Table 74. Europe Nintedanib API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Nintedanib API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Nintedanib API Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Nintedanib API Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Nintedanib API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Nintedanib API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Nintedanib API Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Nintedanib API Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Nintedanib API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Nintedanib API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Nintedanib API Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Nintedanib API Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Nintedanib API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Nintedanib API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Nintedanib API Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Nintedanib API Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Nintedanib API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Nintedanib API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Nintedanib API Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Nintedanib API Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Nintedanib API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Nintedanib API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Teva Corporation Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Teva Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Development
Table 117. Sunshine Pharmaceutical Corporation Information
Table 118. Sunshine Pharmaceutical Description and Major Businesses
Table 119. Sunshine Pharmaceutical Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Sunshine Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sunshine Pharmaceutical Recent Development
Table 122. Fermion Corporation Information
Table 123. Fermion Description and Major Businesses
Table 124. Fermion Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. Fermion Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Fermion Recent Development
Table 127. Tecoland Corporation Information
Table 128. Tecoland Description and Major Businesses
Table 129. Tecoland Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Tecoland Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tecoland Recent Development
Table 132. Enantiotech Corporation Information
Table 133. Enantiotech Description and Major Businesses
Table 134. Enantiotech Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. Enantiotech Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Enantiotech Recent Development
Table 137. Guoding Pharmaceutical Corporation Information
Table 138. Guoding Pharmaceutical Description and Major Businesses
Table 139. Guoding Pharmaceutical Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Guoding Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Guoding Pharmaceutical Recent Development
Table 142. Haiwo Corporation Information
Table 143. Haiwo Description and Major Businesses
Table 144. Haiwo Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Haiwo Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Haiwo Recent Development
Table 147. Beijing Cooperate Pharmaceutical Corporation Information
Table 148. Beijing Cooperate Pharmaceutical Description and Major Businesses
Table 149. Beijing Cooperate Pharmaceutical Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Beijing Cooperate Pharmaceutical Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Beijing Cooperate Pharmaceutical Recent Development
Table 152. Hangzhou Longshine Bio-Tech Corporation Information
Table 153. Hangzhou Longshine Bio-Tech Description and Major Businesses
Table 154. Hangzhou Longshine Bio-Tech Nintedanib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Hangzhou Longshine Bio-Tech Nintedanib API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Hangzhou Longshine Bio-Tech Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Nintedanib API Distributors List
Table 160. Nintedanib API Customers List
Table 161. Nintedanib API Market Trends
Table 162. Nintedanib API Market Drivers
Table 163. Nintedanib API Market Challenges
Table 164. Nintedanib API Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Nintedanib API Product Picture
Figure 2. Global Nintedanib API Market Share by Type in 2021 & 2028
Figure 3. Purity ≥98% Product Picture
Figure 4. Purity ≥99% Product Picture
Figure 5. Global Nintedanib API Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical
Figure 7. Medical Research
Figure 8. Other
Figure 9. Nintedanib API Report Years Considered
Figure 10. Global Nintedanib API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Nintedanib API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Nintedanib API Production Market Share by Region (2017-2022)
Figure 13. Global Nintedanib API Production Market Share by Region (2023-2028)
Figure 14. Nintedanib API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Nintedanib API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Nintedanib API Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Global Nintedanib API Sales 2017-2028 (Tons)
Figure 18. Global Nintedanib API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Nintedanib API Revenue 2017-2028 (US$ Million)
Figure 20. Global Nintedanib API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Nintedanib API Sales Market Share by Region (2017-2022)
Figure 22. Global Nintedanib API Sales Market Share by Region (2023-2028)
Figure 23. North America Nintedanib API Sales YoY (2017-2028) & (Tons)
Figure 24. North America Nintedanib API Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Nintedanib API Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Nintedanib API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Nintedanib API Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Nintedanib API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Nintedanib API Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Nintedanib API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Nintedanib API Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Nintedanib API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Nintedanib API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Nintedanib API in the World: Market Share by Nintedanib API Revenue in 2021
Figure 35. Nintedanib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Nintedanib API Sales Market Share by Type (2017-2028)
Figure 37. Global Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 38. Global Nintedanib API Sales Market Share by Application (2017-2028)
Figure 39. Global Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 40. North America Nintedanib API Sales Market Share by Type (2017-2028)
Figure 41. North America Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 42. North America Nintedanib API Sales Market Share by Application (2017-2028)
Figure 43. North America Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 44. North America Nintedanib API Sales Share by Country (2017-2028)
Figure 45. North America Nintedanib API Revenue Share by Country (2017-2028)
Figure 46. United States Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Nintedanib API Sales Market Share by Type (2017-2028)
Figure 49. Europe Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 50. Europe Nintedanib API Sales Market Share by Application (2017-2028)
Figure 51. Europe Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 52. Europe Nintedanib API Sales Share by Country (2017-2028)
Figure 53. Europe Nintedanib API Revenue Share by Country (2017-2028)
Figure 54. Germany Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 55. France Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Nintedanib API Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Nintedanib API Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Nintedanib API Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Nintedanib API Revenue Share by Region (2017-2028)
Figure 65. China Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 68. India Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Nintedanib API Sales Market Share by Type (2017-2028)
Figure 75. Latin America Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Nintedanib API Sales Market Share by Application (2017-2028)
Figure 77. Latin America Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Nintedanib API Sales Share by Country (2017-2028)
Figure 79. Latin America Nintedanib API Revenue Share by Country (2017-2028)
Figure 80. Mexico Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 83. Colombia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Nintedanib API Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Nintedanib API Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Nintedanib API Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Nintedanib API Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Nintedanib API Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Nintedanib API Revenue Share by Country (2017-2028)
Figure 90. Turkey Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Nintedanib API Revenue (2017-2028) & (US$ Million)
Figure 93. Nintedanib API Value Chain
Figure 94. Nintedanib API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

---